Now Reading
FDA approves Pfizer boosters for 12-15 age group
Subscribe
Sign In

FDA approves Pfizer boosters for 12-15 age group

FDA expanded the Pfizer booster eligibility. 12 to 15-year olds to receive booster shot.

Where: United States

The Facts

The US Food and Drug Administration (FDA) expanded the use of a single booster dose of the Pfizer-BioNTech Covid-19 vaccine to include use in individuals 12-15 years of age.

The FDA also allowed a third dose for certain immunocompromised children aged 5-11 years.

The FDA shortened the time between completion of primary vaccination and a booster dose to five months.

Chairman & CEO Pfizer, Albert Bourla, stated, “The recent rise in COVID-19 cases is concerning to all and today’s decision by the FDA to further expand the Emergency Use Authorization of a booster dose of our vaccine is critical to help us ultimately defeat this pandemic.”

Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention, is expected to rule on the boosters later this week.

Primary Sources

Direct, authoritative source material on this story.

Reference Articles

Articles Citable has ingested related to this story.

Reference Articles

Articles Citable has ingested related to this story.

Media Coverage

Why did we include this story

Most covered story by the media today

of articles referenced this story

Coverage by Media Outlet

Media outlets covering this story along with their positive or negative sentiment toward this story.

© 2021 Citable. All Rights Reserved.